Difficult to Treat Infections and Antimicrobians Use
PRINCIPAL INVESTIGATORS
- M Carmen Cabellos Minguez
- Xavier Ariza Cardenal
CLINICAL RESEARCHERS
- Francisco Javier Cabo Cabo
- Raül Rigo Bonnin
- Laura Soldevila Boixader
- Fe Tubau Quintano
POSTDOCTORAL RESEARCHERS
- Cristina El Haj Hidalgo
PREDOCTORAL RESEARCHERS
- Eva Benavent Palomares
SCIENTIFIC SUPPORT
- Maria Eugenia Agusti Carol
- Lluisa Guillem Tio
Translational Medicine
Infectious disease and transplantation
Scientific production
32
PAPERS
Average IF: 8,171
8
LED PAPERS
Average IF: 8,296
3 PUBLICATIONS IN FIRST DECILE
7 PUBLICATIONS IN FIRST QUARTILE
10 PUBLICATIONS IN OPEN ACCESS
Selected publications
- Soldevila Boixader,L;Mur,I;Morata,L;Sierra,Y;Rivera,A;Bosch,J;Montero Saez,A et al, Clinical usefulness of quantifying microbial load from diabetic foot ulcers: A multicenter cohort study., Diabetes Res. Clin. Pract., 2022;189109975-109975, doi:10.1016/j.diabres.2022.109975,
- Haj,CE;Benavent,E;Sierra,Y;Soldevila,L;Rigo Bonnin,R;Torrejón,B;Gomez Junyent,J et al, Comparative efficacy of dalbavancin alone and with rifampicin against in vitro biofilms in a pharmacodynamic model with methicillin-resistant Staphylococcus aureus., Int. J. Antimicrob. Agents, 2022;60(4):106664-106664, doi:10.1016/j.ijantimicag.2022.106664,
- Espindola,R;Vella,V;Benito,N;Mur,I;Tedeschi,S;Rossi,N;Hendriks,J et al, Preoperative and perioperative risk factors, and risk score development for prosthetic joint infection due to Staphylococcus aureus: A multinational matched case-control study., Clin. Microbiol. Infect., 2022;28(10):1359-1366, doi:10.1016/j.cmi.2022.05.010,
- Espíndola,R;Vella,V;Benito,N;Mur,I;Tedeschi,S;Zamparini,E;Hendriks,J et al, Rates and Predictors of Treatment Failure in Staphylococcus aureus Prosthetic Joint Infections According to Different Management Strategies: A Multinational Cohort Study-The ARTHR-IS Study Group., Infect. Dis. Ther., 2022;11(6):2177-2203, doi:10.1007/s40121-022-00701-0
- Cabellos,C;Guillem,L;Pelegrin,I;Tubau,F;Ardanuy,C;Gudiol,F;Ariza,J et al, Penicillin- and Cephalosporin-Resistant Pneumococcal Meningitis: Treatment in the Real World and in Guidelines., Antimicrob. Agents Chemother., 2022;66(12):doi:10.1128/aac.00820-22
Research highlights
PROJECTS
2 Granted competitive projects
5 Ongoing competitive projects
1 Started clinical trial
3 Ongoing clinical trials
NETWORKS
CIBER-INFEC
AGAUR-SGR GRC
CSUR
Selected projects
- DURATIOM ACNA168/21. Eficacia y seguridad de diferentes duraciones de antimicrobianos para el tratamiento las infecciones asociadas al material de osteosíntesis implantado tras fractura de hueso largo (DURATIOM): ensayo aleatorizado multicéntrico pragmático de fase 3. Instituto de Salud Carlos III (ISCIII). Budget: 429350,9. 2022-2025. PI: Murillo Rubio, Oscar.
- 19FIS018. Vasculitis cerebral post meningitis neumocócica: Factores relacionados y etiopatogenia. Instituto de Salud Carlos III (ISCIII). Budget: 111320. 2019-2023. PI: Cabellos Mínguez, María del Carmen.
- 19MEC020. AYUDAS PARA LA FORMACION DE DOCTORES DEL PROGRAMA NACIONAL DE FORMACION DE PROFESORADO UNIVERSITARIO (FPU). MINISTERIO DE EDUCACIÓN Y FORMACIÓN PROFESIONAL. Budget: 81493,77. 2019-2023. PI: Murillo Rubio, Oscar.
- 21FIS033. CONTRATOS PARA LA INTENSIFICACION DE LA ACTIVIDAD INVESTIGADORA EN EL SNS. Instituto de Salud Carlos III (ISCIII). Budget: 60000. 2021-2022. PI: Murillo Rubio, Oscar.
- 17ACL190. EFFICACY OF DALBAVANCIN, ALONE AND IN COMBINATION, AGAINST IN VITRO FOREIGN-BODY INFECTION CAUSED BY METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS: A PHARMACODYNAMIC STUDY. Budget: 43665,12. 2017- . PI: Murillo Rubio, Oscar.